Items where authors include "Nakafero, G."

Article

Abhishek, A., Nakafero, G. orcid.org/0000-0002-3859-7354, Card, T. orcid.org/0000-0003-2555-2250 et al. (6 more authors) (2025) Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink. BMJ Open Gastroenterology, 12. e001627. ISSN 2054-4774

Abhishek, A. orcid.org/0000-0003-0121-4919, Stevenson, M.D. orcid.org/0000-0002-3099-9877, Nakafero, G. orcid.org/0000-0002-3859-7354 et al. (12 more authors) (2024) Discontinuation of anti-TNF-alpha treatment due to blood test abnormalities and cost-effectiveness of alternate blood monitoring strategies. British Journal of Dermatology, 190 (4). pp. 559-564. ISSN 0007-0963

Abhishek, A. orcid.org/0000-0003-0121-4919, Grainge, M., Card, T. orcid.org/0000-0003-2555-2250 et al. (8 more authors) (2024) Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. RMD Open, 10 (1). e003980. ISSN 2056-5933

Nakafero, G. orcid.org/0000-0002-3859-7354, Card, T., Grainge, M.J. et al. (9 more authors) (2023) Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation. eClinicalMedicine, 64. 102213. ISSN 2589-5370

Nakafero, G. orcid.org/0000-0002-3859-7354, Grainge, M.J., Williams, H.C. et al. (9 more authors) (2023) Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK. BMJ, 381. e074678. ISSN 0959-8138